Recent

% | $
Quotes you view appear here for quick access.

Energy Transfer Partners, L.P. Message Board

burnaka 419 posts  |  Last Activity: Jul 23, 2015 12:03 PM Member since: May 19, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    New insider purchase. Richard Lerner

    by trade56 Jun 9, 2015 4:36 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 11:20 PM Flag

    PS My cuz Miami is part of the package, talk about MOTIVATION.

  • Reply to

    New insider purchase. Richard Lerner

    by trade56 Jun 9, 2015 4:36 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 11:08 PM Flag

    If you own more than Lerner,

    More convinced than ever, YOU ARE ADOPTING me, dad

    Just do it, FROM YOUR LOYAL son, lol.

  • Reply to

    New insider purchase. Richard Lerner

    by trade56 Jun 9, 2015 4:36 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 11:03 PM Flag

    Should read Memorial Sloan and Scardino

  • Reply to

    New insider purchase. Richard Lerner

    by trade56 Jun 9, 2015 4:36 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 10:39 PM Flag

    I believe you are right ICE, and I am wrong. That might be why I could not find a quote, or validation. That said, I did know Opko bought rights from the Swedish company, BUT an opko affiliate MAYBE Scardino was part of that team not Scripps, but Memorial Sloan.

    So anything I said should read Scardino on Nccn guidlines, and MEMORIAL SLOAN not scripps, yes the scripps thing was the Alzheimer blood test platform? dam this memory. HOWEVER a quote.
    Disclosure: Drs. Scardino and Vickers are inventors of the 4K score and are involved in its commercial development. Dr. Scardino is a paid consultant to the company to which the 4K score is licensed.

  • Reply to

    New insider purchase. Richard Lerner

    by trade56 Jun 9, 2015 4:36 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 5:52 PM Flag

    It is a question I have also. I know if there is a conflict they can not vote. Think this way though, Scripps is one of the original members that put the NCCN guidelines out there. Even if Lerner has to refrain from voting his ONE vote, you think the other 20-22 voters will vote against an IDEA he pioneered. I do not. These guys all know and respect each other, Lerner is a heavy weight, you do not tug on his cape so to speak. You can if you want, but in a small group like that, it could be costly down the road if you need backing on something.

    I for one have had the NCCN guidelines as a done deal based on this alone. Shocked if I am wrong.

  • Reply to

    New insider purchase. Richard Lerner

    by trade56 Jun 9, 2015 4:36 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 5:02 PM Flag

    Danged if I can find a quote when I need one, but I believe Lerner was one of the developers of 4kscore while at Scripps institute. Also believe he is on the NCCN prostate committee.

  • burnaka@sbcglobal.net burnaka Jun 9, 2015 4:26 PM Flag

    Usually they will price this in about 2-3 days. Price should bottom tomorrow or Wed., and rise day note sale is complete, and usually with a few days of follow through. Upper 11 range, 11.88 for a bounce to 13 possible 14 over two weeks post note sale. Bet it plays this way. The note buyers usually push it up after closing of the deal with little effort. Weak hands just sold. Short term the funds will let it play this way helping the underwriters too look good with their bigger clients.

  • Reply to

    Please clarify price effective determination

    by miamianne67 Jun 9, 2015 3:43 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 3:58 PM Flag

    Hi Kcuz, Yes the deal happened to be announced, likely signed day opk closed at 19.12 after a steady climb. In retrospect one has to wonder, or not, about who was doing all this buying for near a month prior to the deal with opk hitting several new highs.

    So the bottom line is opk is not paying 52.58 unless opk gets back to 19.12. They are paying 2.75 in shares on the day it closes regardless of where opk is trading. Could be more than 52.85, or less.

    As far as the share price action, to date, it has given the shorts a great opportunity to cut their losses, and hedge them if they pick up BRLI shares on the discrepancy. Figure that is most of the volume. There is also a TON of fund overlap between BRLI and OPK. Funds that were set in opk shares might be switching for an equal number, or keeping their brli and selling here, they get the shares back anyway.

    Betting I over answered your question.

  • Not sure where it settles out, but might be a trade off a bounce. Usually these offerings create a short term trading opportunity if timed right. The terms of the notes, and potential dilution in the future has not been published. Just a trade idea, I only glanced at their pipeline.

  • burnaka@sbcglobal.net burnaka Jun 9, 2015 2:42 PM Flag

    America, they have the right to talk stupid, I have the right to use the ignore button. On occasion shorts can have a good idea, the problem with most however, is they are short term thinkers, in the end many shorts wind up losing most of their gains. They might have a good run for weeks, even years, and get trashed in the end. Look at the performance of short long hedge funds the last 5 years, enough said.

  • will grow even bigger, maybe get to a billion cash on hand in 2-3 years.

  • See the disconnect, talk about no communication. The shorts rant here but they are preaching to a board where the average long is roughly 2.5 years, is that the same as preaching to the choir? Of course they have a motive, to get the new buyer to listen to their spew and to scare them to sell. Will bet this too, the average longs buy price is under 7 on this board, of course ice, and drangles help lower that average considerably.

    The average short, still grossly underwater, even with this pull back, likely average nearer 10-12, than 16.

  • Reply to

    Claros / BRLI

    by oechman Jun 7, 2015 4:12 AM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 12:01 PM Flag

    You hit the nail on the head. Think this way, in addition to opk's 4k, which BRLI will maximize, and opko's other tests, how MANY brli tests can be put on the chip??? THAT is the real grand slam potential of Claros. Not 5-6 tests in under 18 months, but 100 or more tests in the next couple years. Yes Lab and quest need look over their shoulder. The only delay is how fast BRLI research team can ramp up the card technology, but figure 10 times faster than opk alone. They definitely saw this potential. 4k instant big revenue, they have most all insurers and sales force to do that, then putting their patent library on Claros will be the icing.

  • Reply to

    opk

    by debmoss8616 Jun 9, 2015 11:30 AM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 11:38 AM Flag

    Sorry I responded to you, did not realize you had a ten minute old ID created to post nothing of merit, based on nothing of merit. Be careful, all the thought you put into your post might burn out that brain cell.

  • Reply to

    opk

    by debmoss8616 Jun 9, 2015 11:30 AM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 11:35 AM Flag

    WOW, talk about not knowing anything. BUY mutual funds, or take an accounting course, but shooting from the hip with gibberish is not your strength.

  • Reply to

    OT anyone notice nwbo, appears to be breaking out

    by burnaka Jun 8, 2015 3:18 PM
    burnaka@sbcglobal.net burnaka Jun 9, 2015 10:54 AM Flag

    Nwbo has had the potential to be the only stock you need, or a big bust. I got out not because I did not still think it could be a grand slam, but because of the relationship to Cognate, and my thought that cognate would be dumping shares to fund operations. Linda's ties to cognate made me suspicious, so for peace of mind I sold.

    As of today I am not back in, and actually need sell positions I now own if I were to buy back in. I would like to see a pull back into the high 8's to get me motivated. Their LONG awaited phase 1 data, EXCEEDED, all of their other earlier phase studies in one arm from the tinkering of the dendritic
    cell manufacturing process.

    Smith on stocks went over the study well at his site, truly impressive results. I move in and out of things SLOWLY, if it is a good idea today, it will be a good idea in two weeks, even if one has to invest at a higher price.

    Kre8, do not sell your nwbo. As far as posting there, I likely would a little. I post on opk more than any board, a little on arry, but own stocks where I have NEVER posted.

    THE big take away from Smith's analysis was how the nwbo platform could enhance the Merck approved PD1 platform. If nwbo had 18 of 21 still surviving the hint is that number could go up if used in combo. 85% survival rate to 90-100% means do not sell.

  • burnaka@sbcglobal.net burnaka Jun 8, 2015 7:26 PM Flag

    We control them, want proof, post Opk going to 100, that's good for 20 whines, post 50, 15 bashes, post 30, and robo puts it four pages back.. The list of triggers is long, say you are in from 4, or up 300%, they will rant Friday thru Monday on the Merits of selling all. Quiet period, 200 rebuttals, new highs, post after post espousing RSI, like they understand something no one else knows. History of Frost, they bring up tobacco, yada yada. Any time we want, WE make them POST as if the Tasmanian Devil had their tail. We own them, and all 1,2,3 of their grey cells.

  • WE REALLY DO OWN them. Think about it. We get them to have no life, we get them to post night and day in a panic. We get them to spin their wheels, repeat the same ignored gibberish that no one sees ALL weekend long. We have ruined their love lives, their home lives, and taken any degree of sanity and flushed it. Their grey brain cell is always on the verge of exploding, their margin account imploding, all while their bowels are decomposing. Splat hamster on a spinning wheel is unfair to all hamsters, hamsters have no choice. Then again, sad to say, owning a splat hamster, or several splat hamsters as we do, is sad, sad indeed. Impotent in life, impotent on this board, impotent thinking, and believing this behavior moves a stock. Grey brain cell working overtime, xzqspqdf, two brain cells, 4.50, 4.50, 3 brain cells, hanging hammer, u do not to see one of those. WOW did I waste 10 minutes of your time, sorry, that is the time it takes daily to hit ignore. So do hope a FEW of the splat brothers read this and enjoyed doing what they do best, waste their time.

  • Reply to

    To much cheap competition out there....

    by beeestuuu May 29, 2015 10:40 AM
    burnaka@sbcglobal.net burnaka Jun 8, 2015 4:38 PM Flag

    VGR major holders were some of the recent investors in vpco. So you have a player in tobacco and vapor that has put their toe in the door here. VGR vapor is a small % of rev, so this could be an add on to vgr if they decide to make a move.

    I have no position here, but thought I would point to vgr insider list for those figuring this company will be gone, well, more likely absorbed by vgr, but not figuring they pay any large premium, but a realistic possibility.

  • Reply to

    OT anyone notice nwbo, appears to be breaking out

    by burnaka Jun 8, 2015 3:18 PM
    burnaka@sbcglobal.net burnaka Jun 8, 2015 3:24 PM Flag

    I know there has to be at least one NWBO investor here that is doing a dance over this recent run.

ETP
51.20-0.22(-0.43%)Jul 31 4:06 PMEDT